Views & Analysis Astellas wins first Real-World Evidence prize at UK awards UK awards first to introduce a real-world evidence category.
News Pfizer's breast cancer drug step closer to EU approval Ibrance is already Pfizer's top oncology product.
News Novartis/Amgen migraine drug shows promise Mid-stage data suggests drug reduces monthly migraine days.
News Novartis Breezhaler bests GSK's Seretide in COPD Ultibro showed consistent reductions in rate of all exacerbations, whether mild, moderate, or severe.
Views & Analysis Novartis committed to CAR-Ts - but doubts about commercial v... Novartis may have concerns about commercial prospects, says expert.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.